The American Journal of Managed Care: Bolus Insulin Injection Frequency, Smart Pen Engagement Linked With Glycemic Control in T1D A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ... Bolus Insulin Injection Frequency, Smart Pen Engagement Linked With Glycemic Control in T1D Penn Live: Insulin glargine injection pens used by diabetics recalled over missing labels Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S.
Food and Drug Administration, the lack of a label ... (RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ... Healio: Mylan Pharmaceuticals recalls insulin glargine injection pens for potential missing labels Business Wire: Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative
